Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 3 3Phase NA 1Phase 4 1Phase 1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Standard of Care 72Educational Status 60Methods 55Interviews as Topic 55Early Intervention, Educational 53Practice Guidelines as Topic 52Exercise 50Blood Specimen Collection 49Magnetic Resonance Spectroscopy 48Surveys and Questionnaires 47Specimen Handling 40Radiosurgery 31Palliative Care 24Radiotherapy 23Biopsy 20Magnetic Resonance Imaging 16Patient Navigation 15Resistance Training 14Counseling 14Exercise Test 13Diet Therapy 13Therapeutics 11Health Promotion 11Surgical Procedures, Operative 10Referral and Consultation 10Radiation Dose Hypofractionation 10Proton Therapy 10Drug Therapy 10X-Rays 9Telemedicine 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Crizotinib × 90 days × Clear all
NCT02194738 2026-05-13

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

National Cancer Institute (NCI)

Phase NA Active not recruiting
8,300 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡